← Back to Search

Behavioural Intervention

Intensive Transition Support for Chronic Illness

N/A
Waitlist Available
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 to 36 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is evaluating a program called Transition to Adult Care Program at the Hospital for Sick Children, specifically for high-risk youth with complex medical and psychosocial needs transitioning to adult or primary care services.

Who is the study for?
The TAC Program trial is for high-risk youth with multiple chronic physical and/or mental health conditions, or a rare disease/genetic condition. Participants must lack an identified adult care provider post-transfer or face significant social and structural health barriers.
What is being tested?
This study evaluates the Transition to Adult Care (TAC) Program's effectiveness on transition readiness, self-efficacy, self-management, quality of life, and satisfaction in both youth and caregivers during the shift to adult care services.
What are the potential side effects?
Since this trial focuses on support programs rather than medical treatments, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from discussing their conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 to 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 to 36 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Coordinated Transition
Early Identification and Transition Readiness
Early Identification and Transition Readiness - Service Satisfaction
+6 more
Secondary study objectives
Program Feasibility

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
710 Previous Clinical Trials
6,958,070 Total Patients Enrolled
~84 spots leftby May 2027